✦ LIBER ✦

Leukocytapheresis treatment for recurrence Virus C infection in liver transplant recipients

✍ Scribed by V. Morabito; G. Ferretti; M. Rossi; G. Novelli

Book ID: 118452510
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 81 KB
Volume: 16
Category: Article
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2012.05.230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment for Recurrent Hepatitis C Viru

Treatment for Recurrent Hepatitis C Virus Infection After Liver Transplantation

✍ E. Balbi; C.R.G. Leal; L.F. Pacheco-Moreira; F.S. Pousa; M.C. Covelo; A.C. Gonza 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Hepatitis C Virus Recurrence in Living D

Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients

✍ Hector Rodriguez-Luna; Hugo E. Vargas; Pratima Sharma; Jose Ortiz; Giovanni De P 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

Hepatitis C recurrence in liver transpla

Hepatitis C recurrence in liver transplant recipients

✍ T.A. Kizilisik; M. Al-Sebayel; A. Hammad; I. Al-Traif; C.G. Ramirez; A. Abdulla 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Treatment of recurrent hepatitis C virus

Treatment of recurrent hepatitis C virus infection after liver transplantation

✍ Bruna Lavezzo; Mario Rizzetto 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Course of recurrent and acquired hepatit

Course of recurrent and acquired hepatitis C virus infection in liver transplant recipients

✍ G. Dijkstra; E.B. Haagsma; H.T.M. Cuypers; P. Schröder; F. Dijkman; A.S.H. Gouw; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Rimantadine for treatment of hepatitis C

Rimantadine for treatment of hepatitis C infection in liver transplant recipients

✍ Sherman, Kenneth E. ;Sickler, Joelle ;Aranda-Michel, Jaime ;Weber, Frederick L. 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 61 KB 👁 2 views

Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur